RPTX - Repare Therapeutics Inc
2.65
0.020 0.755%
Share volume: 1,219,919
Last Updated: 01-27-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$2.63
0.02
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-07-2024 | 08-06-2024 | 11-07-2024 | 03-03-2025 | 05-13-2025 | 11-14-2025 | |
| Cash flow financing | 375.000 K | 0.000 | 166.000 K | 1.000 K | 79.000 K | 30.000 K | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | 11.932 M | 0.000 | 707.000 K | 4.263 M | -262.000 K | 5.218 M | |
| Net income | 13.162 M | -34.774 M | -34.406 M | -28.671 M | -30.043 M | 3.258 M | |
| Depreciation | 501.000 K | 488.000 K | 478.000 K | 454.000 K | 1.186 M | 72.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 14.206 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -20.316 M | 7.118 M | 31.080 M | 31.586 M | 28.792 M | 2.537 M | |
| Net Borrowings | -237.685 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | 237.001 M | -23.397 M | 721.000 K | 4.176 M | -262.000 K | 5.169 M |